A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
08/2011
08/11/2011	WO2011031063A3 Composition for preventing or treating metabolic disorders, containing the anti-4-1bb antibody
08/11/2011	WO2011003995A9 Product for the storage of freeze-dried lactic acid bacteria mixed with a powder for an oral rehydration solution
08/11/2011	WO2010042543A3 Use of inhibitors of toll-like receptors in the prevention and treatment of hypercholesterolemia and hyperlipidemia and diseases related thereto
08/11/2011	US20110197294 Compositions and methods for restoring mitochondrial electron transfer function
08/11/2011	US20110196042 Compositions and methods for influencing satiety, lipid metabolism, and fat utilization
08/11/2011	US20110196033 Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative or 5-aminolevulinic acid as active ingredient
08/11/2011	US20110196015 N 1-2-thiophene-2-ylethyl-n2-substituted biguanide derivate, preparation method thereof, and pharmaceutical composition containing the same as active ingredients
08/11/2011	US20110196004 Crystalline forms of (r) -5-[3-chloro-4-(2,3-dihydroxy-propoxy)-benz [z] ylidene] -2-( [z]-propylimino) -3-0-tolyl-thiazolidin-4-one
08/11/2011	US20110196002 Diacylglycerol acyltransferase inhibitors
08/11/2011	US20110195994 Piperidinyl GPCR Agonists
08/11/2011	US20110195993 Ppar agonist compounds, preparation and uses
08/11/2011	US20110195992 New compounds ii
08/11/2011	US20110195991 3-aminoimidazo [1,2-a] pyridine derivatives as sglt inhibitors
08/11/2011	US20110195986 Pyrrolone melanin concentrating hormone receptor-1 antagonists
08/11/2011	US20110195985 Compounds for the treatment of lysosomal storage diseases
08/11/2011	US20110195977 Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition
08/11/2011	US20110195974 Methods of treating inflammatory conditions with adrenergic antagonists
08/11/2011	US20110195971 Methods of identifying responders to dopamine agonist therapy
08/11/2011	US20110195970 Methods of identifying and treating responders to dopamine agonist therapy
08/11/2011	US20110195965 Tetrahydro- and dihydroquinazolinones
08/11/2011	US20110195964 Novel cyclic benzimidazole derivatives useful as anti-diabetic agents
08/11/2011	US20110195957 Substituted diazepan orexin receptor antagonists
08/11/2011	US20110195952 Treating psychological conditions using muscarinic receptor m1 antagonists
08/11/2011	US20110195936 Bicyclic sphingosine 1-phosphate analogs
08/11/2011	US20110195935 Nitric oxide releasing amino acid ester compound, composition and method of use
08/11/2011	US20110195934 Azolopyrrolone melanin concentrating hormone receptor-1 antagonists
08/11/2011	US20110195928 Administration of Copper to an Animal
08/11/2011	US20110195917 Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivate
08/11/2011	US20110195897 Glycosylated glp-1 peptide
08/11/2011	US20110195896 Isoform-specific insulin analogues
08/11/2011	US20110195895 Fgf21 mutants and uses thereof
08/11/2011	US20110195844 Process for solubilizing hydrophobic active ingredients in aqueous medium
08/11/2011	US20110195139 Use of overground part of hedychium coronarium koenig in reducing blood glucose; extracts and compositions of overground part of hedychium coronarium koenig and their uses
08/11/2011	US20110195124 Phase-transition polymeric microneedles
08/11/2011	US20110195120 Sustained Release Pharmaceutical Composition Containing Metformin Hydrochloride
08/11/2011	US20110195119 Controlled release metformin formulations
08/11/2011	US20110195115 Hydrophilic amino acid-containing preparation having improved taste
08/11/2011	US20110195080 Compositions and Methods for Enhanced Somatostatin Immunogenicity in the Treatment of Growth Hormone and Insulin-Like Growth Factor One Deficiency
08/11/2011	US20110195077 Methods and compositions using fgf23 fusion ppolypeptides
08/11/2011	US20110195076 Therapeutic agent
08/11/2011	US20110195063 Methods of Treating Ankylosing Spondylitis Using Anti-TNF Antibodies and Peptides of Human Tumor Necrosis Factor
08/11/2011	US20110195031 Methods for the use of progestogen as a glucocorticoid sensitizer
08/11/2011	US20110195023 Internalizing Anti-CD74 Antibodies and Methods of Use
08/11/2011	US20110195022 Cd20 antibodies and uses thereof
08/11/2011	US20110192748 Administration of Dipeptidyl Peptidase Inhibitors
08/11/2011	CA2789144A1 Compositions and methods for treating obesity and obesity-related conditions
08/11/2011	CA2789001A1 Method for treatment of lacto-n-biose-containing solution
08/11/2011	CA2788730A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases
08/11/2011	CA2788416A1 Highly selective 5-ht(2c) receptor agonists having antagonist activity at the 5-ht(2b) receptor
08/11/2011	CA2787360A1 Apoptosis signal-regulating kinase 1 inhibitors
08/11/2011	CA2782444A1 Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof
08/11/2011	CA2731282A1 Anti-fatigue composition
08/10/2011	EP2354213A1 Reduction of sterols and other compounds from oils
08/10/2011	EP2354134A1 2h-chromene compound and derivative thereof
08/10/2011	EP2353605A1 Use of overground part of hedychium coronarium koenig in reducing blood glucose; extracts and compositions of overground part of hedychium coronarium koenig and their uses
08/10/2011	EP2353595A1 Nutritional compensation for western-type diet
08/10/2011	EP2352730A2 Biologically active amides
08/10/2011	EP2352725A1 Quinoxaline-based lxr modulators
08/10/2011	EP2352722A2 Hydroxyadamantyl inhibitors of dipeptidylpeptidase iv
08/10/2011	EP2352514A1 Methods and kits for treating disease by administering insulin-like growth factor binding protein-2
08/10/2011	EP2352511A2 Neuropeptide-2-receptor (y-2r) agonists and uses thereof
08/10/2011	EP2352505A2 D-tagatose-based compositions and methods for preventing and treating atherosclerosis, metabolic syndrome, and symptoms thereof
08/10/2011	EP1968574B1 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
08/10/2011	EP1928840B1 1H-Pyrazole-4-carboxamides, their preparation and their use as 11-beta-hydroxysteroid dehydrogenase inhibitors
08/10/2011	EP1609781B1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine
08/10/2011	EP1496873B2 Chewable soft capsule
08/10/2011	EP1309340B1 High mannose proteins and methods of making high mannose proteins
08/10/2011	CN1562044B Witamin D2 calcium levulinate freeze-dried emulsion and its preparing method
08/10/2011	CN102149717A Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
08/10/2011	CN102149702A Novel methylenedioxy phenolic compounds and their use to treat disease
08/10/2011	CN102149688A New benzimidazole derivatives
08/10/2011	CN102149680A Nitrogen-containing aromatic heterocyclyl compound
08/10/2011	CN102149407A Combination therapy for the treatment of diabetes and related conditions
08/10/2011	CN102149399A Method for producing a composition with a high content of sapogenin
08/10/2011	CN102149375A Human Beta3 adrenergic receptor ligand, and food or pharmaceutical product containing the same
08/10/2011	CN102146143A Method for preparing pectin and cellulose from extracting residues of ginseng and American ginseng and application thereof
08/10/2011	CN102146078A Substituted propanamide compounds and preparation method and application thereof
08/10/2011	CN102146074A Preparation method of pyrrole derivative and application thereof
08/10/2011	CN102146066A C-glucoside derivatives containing saturated six-membered ring as well as preparation method and application thereof
08/10/2011	CN102146040A 2-(4-Chlorophenoxy)-2-methylpropionic acid methoxyphenyl propionate compound and synthesis method thereof
08/10/2011	CN102146014A Method for extracting squalene by using camellia oleosa seeds as raw materials and tea oil and squalene soft capsules
08/10/2011	CN102145174A Chondroitin sulfate nano-selenium and preparation method thereof
08/10/2011	CN102145164A IAPP (Islet Amyloid Polypeptide) analog injection with better stability
08/10/2011	CN102145163A Use of CNTF (ciliary neurotrophic factor) receptor activators for the treatment of obesity
08/10/2011	CN102145128A Medicinal composition for preventing and treating cardiac and cerebral vascular diseases and preparation method thereof
08/10/2011	CN102145125A Propolis and aweto capsule for treating diabetes
08/10/2011	CN102145121A Chinese medical preparation assisting to adjusting blood sugar
08/10/2011	CN102145120A Traditional Chinese medicine composition suitable for treating Type II diabetes
08/10/2011	CN102145087A Traditional Chinese medicine preparation for regulating blood fat
08/10/2011	CN102145085A Traditional Chinese medicinal health-care tea for preventing and treating hyperlipemia
08/10/2011	CN102145062A Active extracts of rosa roxburghii tratt fruit, and preparation method, detection method and application thereof
08/10/2011	CN102145060A Dual-cordis effect of Xin Keshu
08/10/2011	CN102145045A Externally-applied weight reducing drug
08/10/2011	CN102145041A Pharmaceutical composition with function of treating polycystic ovary syndrome
08/10/2011	CN102145023A Formula of traditional Chinese medicinal decoction for treating diabetes and preparation process thereof
08/10/2011	CN102145009A Octadeca compound amino acid injection and preparation method thereof
08/10/2011	CN102144985A Potassium chloride elementary osmotic pump controlled release tablet and preparation method thereof
08/10/2011	CN102144976A Method for preparing insulin dry powder for oral administration by using micro capsulation technology
08/10/2011	CN102144968A Oral suspension of liposome-encapsulated insulin lyophilized preparation and preparation process thereof
08/10/2011	CN101904983B Internal medicament for treating diabetes

1 ... 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 ... 1298